A.L.T.

Hot Off The Wires

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with … 12/4/2023

Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity … 11/30/2023

89bio Announces New Positive Long-Term Data from the ENLIVEN Phase 2b … 11/27/2023

Be My Eyes Integrates Be My AI™ into its First Contact Center … 11/15/2023

Tessellate BIO, an Emerging Precision Oncology Company, Announces the Appointment of World-… 11/15/2023

Voice Cloning Market Size to Grow USD 1723.9 Million by 2029 … 11/14/2023

Amazon's Buy with Prime Kicks Off the Holiday Season by Offering … 11/14/2023

NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial … 11/13/2023

89bio Announces Additional Data from the ENLIVEN Phase 2b Trial of Pegozafermin … 11/12/2023

BTCS Reports Q3 2023 Results 11/10/2023

Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN … 11/10/2023

Crystal Group Donates 11 Servers to Two Kirkwood Community College Programs 11/9/2023

SPEC Delivers Major Update to SPECaccel Benchmark Suite 11/9/2023

HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) … 11/9/2023

Innovative Female Wellness Platform Yoona Closes 7-Figure Seed Round 11/8/2023

more news »

Quicklinks